Novartis Ag (NVSEF) Exchange Rate Effect (2009 - 2026)

Novartis Ag has disclosed Exchange Rate Effect across 13 years of filings, most recently posting -$77.0 million for Q1 2026.

• Exchange Rate Effect for Q1 2026 came in at -$77.0 million, down 142.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $319.0 million (up 3887.5% YoY), and the FY2025 annual result was $576.0 million, up 293.29% from the prior year.
• Exchange Rate Effect came in at -$77.0 million for Q1 2026 at Novartis Ag, down from $36.0 million in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $382.0 million in Q2 2025 to a low of -$314.0 million in Q4 2024.
• The 5-year median for Exchange Rate Effect is -$22.0 million (2025), against an average of $15.8 million.
• Across the five-year window, Exchange Rate Effect plunged 3300.0% in 2024 and soared 1223.53% in 2025, its largest moves.
• Novartis Ag's Exchange Rate Effect stood at $141.0 million in 2022, then grew by 13.48% to $160.0 million in 2023, then slumped by 296.25% to -$314.0 million in 2024, then surged by 111.46% to $36.0 million in 2025, then plunged by 313.89% to -$77.0 million in 2026.
• The last three Exchange Rate Effect figures came in at -$77.0 million (Q1 2026), $36.0 million (Q4 2025), and -$22.0 million (Q3 2025), per Business Quant data.